| 1 |
32431514 | Tetrandrine Reverses Paclitaxel Resistance in Human Ovarian Cancer via Inducing Apoptosis, Cell Cycle Arrest Through β-Catenin Pathway. | 2020 |
1 |
| 2 |
32435154 | HE4 overexpression decreases pancreatic cancer Capan-1 cell sensitivity to paclitaxel via cell cycle regulation. | 2020 |
1 |
| 3 |
32647677 | Natural compound Tan-I enhances the efficacy of Paclitaxel chemotherapy in ovarian cancer. | 2020 Jun |
1 |
| 4 |
31140859 | EZH2 Confers Sensitivity of Breast Cancer Cells to Taxol by Attenuating p21 Expression Epigenetically. | 2019 Jul |
3 |
| 5 |
28884602 | Enhancement of anticancer activity by silibinin and paclitaxel combination on the ovarian cancer. | 2018 Nov |
1 |
| 6 |
30008912 | β-elemene enhances anticancer bone neoplasms efficacy of paclitaxel through regulation of GPR124 in bone neoplasms cells. | 2018 Aug |
1 |
| 7 |
28522974 | Low-Dose Paclitaxel Inhibits Tumor Cell Growth by Regulating Glutaminolysis in Colorectal Carcinoma Cells. | 2017 |
1 |
| 8 |
28991260 | Protein and chemotherapy profiling of extracellular vesicles harvested from therapeutic induced senescent triple negative breast cancer cells. | 2017 Oct 9 |
1 |
| 9 |
26794658 | Targeting HDAC with a novel inhibitor effectively reverses paclitaxel resistance in non-small cell lung cancer via multiple mechanisms. | 2016 Jan 21 |
1 |
| 10 |
27687545 | Mechanism of paclitaxel resistance in a human prostate cancer cell line, PC3-PR, and its sensitization by cabazitaxel. | 2016 Oct 28 |
1 |
| 11 |
23628417 | Tumor suppressor BLU promotes paclitaxel antitumor activity by inducing apoptosis through the down-regulation of Bcl-2 expression in tumorigenesis. | 2013 May 24 |
1 |
| 12 |
22808086 | Lin28 mediates paclitaxel resistance by modulating p21, Rb and Let-7a miRNA in breast cancer cells. | 2012 |
1 |
| 13 |
16364249 | TP53 and P21 polymorphisms: response to cisplatinum/paclitaxel-based chemotherapy in ovarian cancer. | 2006 Feb 3 |
1 |
| 14 |
16616141 | Evidence that low doses of Taxol enhance the functional transactivatory properties of p53 on p21 waf promoter in MCF-7 breast cancer cells. | 2006 Apr 17 |
4 |
| 15 |
14719078 | Protein levels of p21, p27, cyclin E and Bax predict sensitivity to cisplatin and paclitaxel in head and neck squamous cell carcinomas. | 2004 Feb |
1 |
| 16 |
14975768 | Bcl-2 and Bcl-xL are important for the induction of paclitaxel resistance in human hepatocellular carcinoma cells. | 2004 Mar 12 |
1 |
| 17 |
12518324 | Experimental therapy of human prostate cancer by inhibiting MDM2 expression with novel mixed-backbone antisense oligonucleotides: in vitro and in vivo activities and mechanisms. | 2003 Feb 15 |
1 |
| 18 |
12574211 | p21 Waf-1 (Cip-1) enhances apoptosis induced by manumycin and paclitaxel in anaplastic thyroid cancer cells. | 2003 Feb |
6 |
| 19 |
12761496 | Paclitaxel increases p21 synthesis and accumulation of its AKT-phosphorylated form in the cytoplasm of cancer cells. | 2003 May 22 |
6 |
| 20 |
14751837 | Chemosensitization and radiosensitization of human cancer by antisense anti-MDM2 oligonucleotides: in vitro and in vivo activities and mechanisms. | 2003 Dec |
1 |
| 21 |
12150453 | Overexpression of cyclin D1 enhances taxol induced mitotic death in MCF7 cells. | 2002 Jul |
2 |
| 22 |
12168940 | Correlation of clinical outcome with p53 and p21 status in patients with advanced transitional-cell carcinoma treated with paclitaxel and carboplatin. | 2002 Mar-Apr |
2 |
| 23 |
12384528 | Enhanced sensitization to taxol-induced apoptosis by herceptin pretreatment in ErbB2-overexpressing breast cancer cells. | 2002 Oct 15 |
2 |
| 24 |
11439344 | Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity. | 2001 Jun 28 |
4 |
| 25 |
11025661 | p53 is associated with cellular microtubules and is transported to the nucleus by dynein. | 2000 Oct |
1 |
| 26 |
11129289 | Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft models. | 2000 Nov |
1 |
| 27 |
10321832 | Extracellular matrix inhibits apoptosis and enhances endothelial cell differentiation by a NfkappaB-dependent mechanism. | 1999 Jun 1 |
2 |
| 28 |
10424768 | Sequence-dependent antagonism between fluorouracil and paclitaxel in human breast cancer cells. | 1999 Aug 1 |
1 |
| 29 |
9419978 | Involvement of p21 in mitotic exit after paclitaxel treatment in MCF-7 breast adenocarcinoma cell line. | 1997 Dec 4 |
8 |